NIH Licenses Gene-Editing Breakthrough to Cure Rare ROSAH Syndrome Vision Loss
Published Date: 3/20/2026
Notice
Summary
The National Institutes of Health is offering a cool new gene-editing invention that can fix a rare genetic disease called ROSAH syndrome, which causes vision loss and other problems. Companies can license this technology to develop treatments that might restore vision and improve lives. Interested parties should act soon and be ready to sign a confidentiality agreement to get all the details.
Analyzed Economic Effects
6 provisions identified: 4 benefits, 2 costs, 0 mixed.
Potential Vision-Restoring Therapy For ROSAH
Researchers report a gene-editing method that precisely repairs the ALPK1 p.Thr237Met mutation in patient-derived cells with high accuracy and no side effects in lab tests, and the therapy could be delivered to the eye or salivary glands or via corrected patient cells returned to the patient. This technology could, if developed and commercialized, offer personalized treatment to restore vision and improve quality of life for people with ROSAH syndrome.
Government Gene-Editing Available for Licensing
The National Institute of Allergy and Infectious Diseases (NIAID) is offering a gene-editing technology that fixes the ALPK1 p.Thr237Met mutation (causing ROSAH syndrome) for licensing to commercial developers under 35 U.S.C. 209 and 37 CFR part 404. Companies interested in commercializing the invention should reference HHS Reference No. E-044-2024-0 when contacting the licensing office.
Agency Seeking Research Collaborators
NIAID is seeking statements of capability or interest from parties for collaborative research to further develop, evaluate, or commercialize this technology, with specific interest in human clinical trials. Parties that want to collaborate should contact David Yang at 240-695-6406 or [email protected].
Patent Filings Extend Market Coverage
Intellectual property associated with this invention includes Provisional Patent Application No. 63/733,836 filed December 13, 2024, and PCT Patent Application No. PCT/US2025/059432 filed December 12, 2025; foreign patent applications have been filed on selected inventions and may be available for licensing to extend market coverage. Reference: HHS Reference No. E-044-2024-0.
Technology Is At Pre-Clinical Stage
The notice states the invention's development stage as "Pre-Clinical," indicating it has laboratory results but has not yet entered human clinical trials. NIAID specifically notes interest in collaborators for human clinical trials to advance development.
Confidentiality Agreement Needed For Details
To receive copies of unpublished information about the invention, interested parties must sign a Confidential Disclosure Agreement (CDA) before NIAID will share full details. Contact David Yang at 240-695-6406 or [email protected] to request information and the CDA.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2026-05526, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 16, 2026, to review and evaluate grant applications and contract proposals. These meetings protect private info and trade secrets, so the public can’t attend. Researchers and organizations applying for funding should note these important review dates as they impact which projects get supported.
Next: 2026-05528, Agency Information Collection Activities; Comment Request; State Workforce Program Certification
The Department of Education wants your thoughts on a new form for State Workforce Programs to certify their info. This helps make sure the government collects only what’s needed without extra hassle. If you’re involved with these programs, you can comment by May 19, 2026—no cost changes, just smoother paperwork!